Pyoderma gangrenosum after mRNA-based SARS-CoV-2 vaccine.
作者信息
Franceschi J, Darrigade A S, Sanchez-Pena P, Legrain-Lifermann V, Milpied B
机构信息
Department of Dermatology, Bordeaux University Hospital, Bordeaux cedex, France.
Regional Center of Pharmacovigilance, Pharmacology Department, Bordeaux University Hospital, Bordeaux cedex, France.
出版信息
J Eur Acad Dermatol Venereol. 2022 Dec;36(12):e969-e970. doi: 10.1111/jdv.18389. Epub 2022 Jul 11.
Abstract
摘要
相似文献
1
Pyoderma gangrenosum after mRNA-based SARS-CoV-2 vaccine.基于mRNA的新型冠状病毒2型疫苗接种后发生坏疽性脓皮病
J Eur Acad Dermatol Venereol. 2022 Dec;36(12):e969-e970. doi: 10.1111/jdv.18389. Epub 2022 Jul 11.
2
A case of recurrence of pyoderma gangrenosum after COVID-19 vaccine.1例新冠疫苗接种后坏疽性脓皮病复发病例。
J Eur Acad Dermatol Venereol. 2023 Nov;37(11):e1261-e1263. doi: 10.1111/jdv.19285. Epub 2023 Jun 29.
3
Haemorrhagic bullous pyoderma gangrenosum following COVID-19 vaccination.新冠病毒疫苗接种后出现的出血性大疱性坏疽性脓皮病
J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e611-e613. doi: 10.1111/jdv.18132. Epub 2022 Apr 18.
4
Immediate reactions after mRNA SARS-CoV-2 vaccination.新型冠状病毒mRNA疫苗接种后的即时反应。
CMAJ. 2021 Dec 6;193(48):E1842. doi: 10.1503/cmaj.211581. Epub 2021 Nov 12.
5
Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over.12岁及以上囊性纤维化患者中基于mRNA的SARS-CoV-2疫苗的安全性。
J Cyst Fibros. 2022 May;21(3):e173-e175. doi: 10.1016/j.jcf.2022.02.009. Epub 2022 Feb 16.
6
Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.在首次发生免疫性血小板减少性紫癜后成功进行mRNA SARS-CoV-2疫苗再次接种。
Platelets. 2022 May 19;33(4):652-653. doi: 10.1080/09537104.2022.2044463. Epub 2022 Feb 28.
7
Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.川崎病病史患者对 COVID-19 感染和信使 RNA 疫苗接种的耐受性。
JAMA Netw Open. 2022 Aug 1;5(8):e2226236. doi: 10.1001/jamanetworkopen.2022.26236.
8
Seroconversion after SARS-CoV-2 mRNA booster vaccine in cancer patients.癌症患者接种新型冠状病毒mRNA加强疫苗后的血清转化
Eur J Cancer. 2022 May;167:175-176. doi: 10.1016/j.ejca.2022.02.032. Epub 2022 Mar 15.
9
Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [Comirnaty]).因 SARS-CoV-2 疫苗（辉瑞-生物科技 BNT162b2 信使 RNA COVID-19 疫苗[Comirnaty]）而引发的急性哮喘恶化。
Int J Infect Dis. 2022 Nov;124:187-189. doi: 10.1016/j.ijid.2022.09.019. Epub 2022 Sep 16.
10
Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle?mRNA 新型冠状病毒疫苗是否会影响患者在试管婴儿-胚胎移植周期中的表现？
Reprod Biol Endocrinol. 2021 May 13;19(1):69. doi: 10.1186/s12958-021-00757-6.
引用本文的文献
1
Exacerbation of Behcet's Disease and Pyoderma Gangrenosum Following COVID-19 Infection: A Case Report.新冠病毒感染后白塞病和坏疽性脓皮病病情加重：一例报告
Cureus. 2023 Nov 25;15(11):e49386. doi: 10.7759/cureus.49386. eCollection 2023 Nov.
2
Pyoderma Gangrenosum: Treatment Options.坏疽性脓皮病：治疗选择。
Drugs. 2023 Sep;83(14):1255-1267. doi: 10.1007/s40265-023-01931-3. Epub 2023 Aug 23.
3
Pyoderma Gangrenosum Triggered by COVID-19 Vaccination in a Patient with Ulcerative Colitis: A Case Report.溃疡性结肠炎患者接种新冠疫苗引发坏疽性脓皮病：一例报告
Int J Low Extrem Wounds. 2022 Nov 25:15347346221141173. doi: 10.1177/15347346221141173.
Zotero 插件